Ge Healthcare Technologies Inc. (GEHC) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Ge Healthcare Technologies Inc. (GEHC) stock forecast summary
Our AI ranks Ge Healthcare Technologies Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Ge Healthcare Technologies Inc. is a large-cap company with a market capitalization of $31.29B.
A per-ticker accuracy statistic for GEHC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, GEHC included.
Follow GEHC freeGEHC price chart and AI forecast
How GEHC ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Ge Healthcare Technologies Inc. (GEHC) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the X-Ray Apparatus & Tubes & Related Irradiation Apparatus peers listed below that report each metric.
Valuation & Market
| Metric | GEHC | Rank |
|---|---|---|
| Market Cap | $31.29B | – |
| P/E Ratio | 15.44x | – |
| P/B Ratio | 2.76x | – |
| Dividend Yield | 0.22% | – |
| EPS | $4.17 | – |
| Book Value/Share | $24.89 | – |
| Revenue/Share | $46.12 | – |
| FCF/Share | $3.34 | – |
Profitability & Margins
| Metric | GEHC | Rank |
|---|---|---|
| ROE | 17.9% | – |
| ROA | 5.1% | – |
| ROIC | 9.3% | – |
| Gross Margin | 39.1% | – |
| Operating Margin | 12.6% | – |
| Net Margin | 9.1% | – |
| EBT Margin | 12.3% | – |
| Tax Rate | 23.4% | – |
Financial Health
| Metric | GEHC | Rank |
|---|---|---|
| Current Ratio | 1.22x | – |
| Quick Ratio | 0.95x | – |
| D/E Ratio | 2.46x | – |
| Financial Leverage | 3.48x | – |
| Interest Coverage | 5.9x | – |
| Working Capital | $1.90B | – |
Cash Flow
| Metric | GEHC | Rank |
|---|---|---|
| Operating Cash Flow | $2.03B | – |
| Free Cash Flow | $1.52B | – |
| Capital Spending | -$508M | – |
| OCF Growth YoY | 13.8% | – |
| FCF Growth YoY | 10.6% | – |
| FCF/Sales | 7.2% | – |
| CapEx/Sales | 2.4% | – |
Operational Efficiency
| Metric | GEHC | Rank |
|---|---|---|
| Asset Turnover | 0.57x | – |
| Receivables Turnover | 6.2x | – |
| Fixed Assets Turnover | 7.8x | – |
| Days Sales Outstanding | 59 days | – |
Income Statement
| Metric | GEHC | Rank |
|---|---|---|
| Total Revenue | $20.98B | – |
| Operating Income | $2.65B | – |
| Net Income | $1.91B | – |
| R&D Expense | $1.26B | – |
| SG&A Expense | $4.30B | – |
Dividend & Shareholder Information
| Metric | GEHC | Rank |
|---|---|---|
| Dividends Per Share | $0.15 | – |
| Payout Ratio | 3.6% | – |
| Shares Outstanding | 455M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $10.43B | 28.1% of assets |
| Cash & Short-term Investments | $2.26B | 6.1% of assets |
| Accounts Receivable | $3.37B | 9.1% of assets |
| Inventory | $2.35B | 6.3% of assets |
| Total Liabilities | $26.23B | 70.6% of assets |
| Short-term Debt | $5.12B | 13.8% of assets |
GEHC quarterly financials and insider trading
Ge Healthcare Technologies Inc. (GEHC) industry peers
Companies classified under the same SEC industry code as Ge Healthcare Technologies Inc. (X-Ray Apparatus & Tubes & Related Irradiation Apparatus): 3 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere GEHC sits on the market map
Ge Healthcare Technologies Inc. (GEHC) stock news
Loading...
Ge Healthcare Technologies Inc. (GEHC) stock forecast FAQ
What is the Ge Healthcare Technologies Inc. (GEHC) stock forecast?
Our AI ranks Ge Healthcare Technologies Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Ge Healthcare Technologies Inc. stock predictions?
A per-ticker accuracy statistic for GEHC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Ge Healthcare Technologies Inc. forecasts updated?
Ge Healthcare Technologies Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Ge Healthcare Technologies Inc.'s industry peers?
3 issuers in our coverage, GEHC included, share the SEC industry code X-Ray Apparatus & Tubes & Related Irradiation Apparatus. The largest are: Koninklijke Philips Nv (PHG), Butterfly Network, Inc. (BFLY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.